Jaimin Rangwalla, CIO of Public Investments at Coatue, sat down with @MollySOShea to walk through unexpected winners of the AI cycle.
The full conversation is live ⬇️
.@OpenAI has closed a $122 billion Growth Round - the largest private fundraise in history.
This milestone reflects more than just capital; it underscores the massive scale and accelerating adoption of frontier AI across the global economy.
We are proud to follow on and continue our partnership with the OpenAI team as they help define the future of the intelligence era.
Got married on Saturday to the love of my life. Two weeks prior, our original wedding venue Cooper Hewitt, federal property, closed because of the US government shutdown.
We got married in our friend’s backyard instead and had the best day of our lives.
Artera is thrilled to announce its public launch today, with $90M in funding. This investment will help distribute Artera’s flagship test, the #ArteraAI Prostate Test - the first test ever to predict therapy benefit in localized #prostatecancer: https://t.co/bxVcNILA7V
Coatue is excited to be an investor in Tome! 🎉
I created my first Tome about the stories I share with my son each evening.❤️The power of stories exists at every stage and age, and Tome reimagines slides to help tell better stories.
See it here:
https://t.co/sD7buvQn5d
I'm excited to be joining @reidhoffman on the board of Tome which is coming out of stealth today founded by @keithpeiris@hliriani. Here's a thread about my leadership journey created in Tome:
https://t.co/5LLSSI8ynM
We have completed our #SeriesC financing, raising $200M total! This round’s proceeds will be used to advance the #SYNTAX Platform, our benchtop #EDS printer. Read: https://t.co/baMVTEsK3O #synbio
Hinge Health, a provider of digital physical therapy, raises $400 million in a financing round that more than doubles its valuation from January https://t.co/JwjcJqFzpI
Big news! We've closed our oversubscribed #SeriesC fundraising round at $165M! The new funds will be used to accelerate applications expansion & commercialization of our revolutionary #SYNTAX Platform and broaden our #EDS product portfolio. More: https://t.co/6v6nkTGSNN
#biotech